|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Creighton CJ, Morgan M, Gunaratne PH,
Wheeler DA, Gibbs RA, Robertson A, Chu A, Beroukhim R, Cibulskis K,
Signoretti S, et al: Comprehensive molecular characterization of
clear cell renal cell carcinoma. Nature. 499:43–49. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng L, Zhang S, MacLennan GT,
Lopez-Beltran A and Montironi R: Molecular and cytogenetic insights
into the pathogenesis, classification, differential diagnosis, and
prognosis of renal epithelial neoplasms. Hum Pathol. 40:10–29.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morris MR, Ricketts C, Gentle D,
Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Latif F and
Maher ER: Identification of candidate tumour suppressor genes
frequently methylated in renal cell carcinoma. Oncogene.
29:2104–2117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peters I, Rehmet K, Wilke N, Kuczyk MA,
Hennenlotter J, Eilers T, Machtens S, Jonas U and Serth J: RASSF1A
promoter methylation and expression analysis in normal and
neoplastic kidney indicates a role in early tumorigenesis. Mol
Cancer. 6:492007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Atschekzei F, Hennenlotter J, Jänisch S,
Großhennig A, Tränkenschuh W, Waalkes S, Peters I, Dörk T,
Merseburger AS, Stenzl A, et al: SFRP1 CpG island methylation locus
is associated with renal cell cancer susceptibility and disease
recurrence. Epigenetics. 7:447–457. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Onay H, Pehlivan S, Koyuncuoglu M, Kirkali
Z and Ozkinay F: Multigene methylation analysis of conventional
renal cell carcinoma. Urol Int. 83:107–112. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Caceres Ibanez I, Dulaimi E, Hoffman
AM, Al-Saleem T, Uzzo RG and Cairns P: Identification of novel
target genes by an epigenetic reactivation screen of renal cancer.
Cancer Res. 66:5021–5028. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Morris MR, Gentle D, Abdulrahman M, Clarke
N, Brown M, Kishida T, Yao M, Teh BT, Latif F and Maher ER:
Functional epigenomics approach to identify methylated candidate
tumour suppressor genes in renal cell carcinoma. Br J Cancer.
98:496–501. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dubrowinskaja N, Gebauer K, Peters I,
Hennenlotter J, Abbas M, Scherer R, Tezval H, Merseburger AS,
Stenzl A, Grünwald V, et al: Neurofilament Heavy polypeptide CpG
island methylation associates with prognosis of renal cell
carcinoma and prediction of antivascular endothelial growth factor
therapy response. Cancer Med. 3:300–309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Henrique R, Luís AS and Jerónimo C: The
epigenetics of renal cell tumors: From biology to biomarkers. Front
Genet. 3:942012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watanabe TK, Katagiri T, Suzuki M, Shimizu
F, Fujiwara T, Kanemoto N, Nakamura Y, Hirai Y, Maekawa H and
Takahashi EI: Cloning and characterization of two novel human cDNAs
(NELL1 and NELL2) encoding proteins with six EGF-like repeats.
Genomics. 38:273–276. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ting K, Vastardis H, Mulliken JB, Soo C,
Tieu A, Do H, Kwong E, Bertolami CN, Kawamoto H, Kuroda S, et al:
Human NELL-1 expressed in unilateral coronal synostosis. J Bone
Miner Res. 14:80–89. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aghaloo T, Cowan CM, Chou YF, Zhang X, Lee
H, Miao S, Hong N, Kuroda S, Wu B, Ting K, et al: Nell-1-induced
bone regeneration in calvarial defects. Am J Pathol. 169:903–915.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maeda K, Matsuhashi S, Tabuchi K, Watanabe
T, Katagiri T, Oyasu M, Saito N and Kuroda S: Brain specific human
genes, NELL1 and NELL2, are predominantly expressed in
neuroblastoma and other embryonal neuroepithelial tumors. Neurol
Med Chir. 41:582–589. 2001. View Article : Google Scholar
|
|
16
|
Shah US and Getzenberg RH: Fingerprinting
the diseased prostate: Associations between BPH and prostate
cancer. J Cell Biochem. 91:161–169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Osman I, Bajorin DF, Sun TT, Zhong H,
Douglas D, Scattergood J, Zheng R, Han M, Marshall KW and Liew CC:
Novel blood biomarkers of human urinary bladder cancer. Clin Cancer
Res. 12:3374–3380. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Slovak ML, Bedell V, Hsu YH, Estrine DB,
Nowak NJ, Delioukina ML, Weiss LM, Smith DD and Forman SJ:
Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease
onset reveal distinct copy number alterations in chemosensitive
versus refractory Hodgkin lymphoma. Clin Cancer Res. 17:3443–3454.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakamura R, Oyama T, Tajiri R, Mizokami A,
Namiki M, Nakamoto M and Ooi A: Expression and regulatory effects
on cancer cell behavior of NELL1 and NELL2 in human renal cell
carcinoma. Cancer Sci. 106:656–664. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gebauer K, Peters I, Dubrowinskaja N,
Hennenlotter J, Abbas M, Scherer R, Tezval H, Merseburger AS,
Stenzl A, Kuczyk MA, et al: Hsa-mir-124-3 CpG island methylation is
associated with advanced tumours and disease recurrence of patients
with clear cell renal cell carcinoma. Br J Cancer. 108:131–138.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sobin LH and Compton CC: TNM seventh
edition: What's new, what's changed: Communication from the
international union against cancer and the American Joint Committee
on cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peters I, Eggers H, Atschekzei F,
Hennenlotter J, Waalkes S, Tränkenschuh W, Grosshennig A,
Merseburger AS, Stenzl A, Kuczyk MA, et al: GATA5 CpG island
methylation in renal cell cancer: A potential biomarker for
metastasis and disease progression. BJU Int. 110:E144–E152. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Colella S, Shen L, Baggerly KA, Issa JP
and Krahe R: Sensitive and quantitative universal Pyrosequencing
methylation analysis of CpG sites. Biotechniques. 35:146–150. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Team RDC: R Development Core Team. 2011.
R: A language and environment for statistical computingR Foundation
for Statistical Computing. Vienna, Austria: http://www.R-project.org/
|
|
25
|
Mori Y, Cai K, Cheng Y, Wang S, Paun B,
Hamilton JP, Jin Z, Sato F, Berki AT, Kan T, et al: A genome-wide
search identifies epigenetic silencing of somatostatin,
tachykinin-1, and 5 other genes in colon cancer. Gastroenterology.
131:797–808. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin Z, Mori Y, Yang J, Sato F, Ito T,
Cheng Y, Paun B, Hamilton JP, Kan T, Olaru A, et al:
Hypermethylation of the nel-like 1 gene is a common and early event
and is associated with poor prognosis in early-stage esophageal
adenocarcinoma. Oncogene. 26:6332–6340. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao C and Zhang Q, Kong D, Wu D, Su C,
Tong J, Chen F and Zhang Q: MALDI-TOF Mass Array analysis of Nell-1
promoter methylation patterns in human gastric cancer. Biomed Res
Int. 2015:1369412015. View Article : Google Scholar : PubMed/NCBI
|
